Skip to main content

Kids with Down syndrome

Kids with Down syndrome can live 'abundant lives,' dad tells Fox News contributor


Fox News contributor Tom Shillue speaks to the dad of a child with Down syndrome on World Down Syndrome Day. Each year on March 21, World Down Syndrome Day (WDSD) marks a global day of awareness and education about the genetic condition.

The goal is to "help people understand and support those with Down syndrome better," according to the initiative's website. WDSD has been officially observed by the United Nations since 2012. On Friday, Fox News contributor Tom Shillue headed to Times Square in New York City to speak with New Yorkers about their awareness of WDSD. (See the video at the top of this article.)

Shillue spoke with Daniel Schreck, chairman of the Jérôme Lejeune Foundation, a global nonprofit focused on research and advocacy for people with genetic intellectual disabilities. Schreck also has a daughter with Down syndrome. When asked about common fears or misunderstandings about the condition, Schreck spoke of the perceived limitations. "I think the most important thing is that if you have Down syndrome, just like any other disability, you can live an abundant life and there's nothing to be afraid of," he said.

FAMILY OF CHILD WITH DOWN SYNDROME WENT FROM SHOCK TO GRATITUDE: ‘LOST THE AIR IN MY CHEST’

"Plus, people with Down's syndrome are the happiest people you've ever met. So there's nothing to be afraid of." The date of WDSD, the 21st day of the third month, was chosen to commemorate the triplication (trisomy) of the 21st chromosome, which is the cause of Down syndrome. Down syndrome is the most common chromosomal condition.

Down syndrome, trisomy 21, genetic disorder, intellectual disability, developmental delay, chromosomal abnormality, hypotonia, congenital heart disease, speech therapy, occupational therapy, early intervention, inclusive education, special needs, genetic counseling, physical therapy, facial features, prenatal screening, cognitive development, social inclusion, adaptive skills,

#DownSyndrome #Trisomy21 #GeneticDisorder #IntellectualDisability #DevelopmentalDelay #SpecialNeeds #InclusiveEducation #EarlyIntervention #SpeechTherapy #OccupationalTherapy #PhysicalTherapy #GeneticCounseling #SocialInclusion #CognitiveDevelopment #AdaptiveSkills #Hypotonia #CongenitalHeartDisease #PrenatalScreening #ChromosomalAbnormality #DownSyndromeAwareness

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Post a Comment

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
Post a Comment
Read more

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more